Literature DB >> 17619133

Marek's disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8 kb mRNA transcripts.

Jiabo Ding1, Zhizhong Cui, Lucy F Lee.   

Abstract

The pp38 and pp24 genes of Marek's diseases virus (MDV) share the same promoter, which controls the transcription of pp38 or pp24 and a 1.8-kb mRNA bi-directionally. To understand the trans-activating activity of pp38 and pp24 on the bi-directional promoter, both genes were cloned into pcDNA-3 or pBudCE4.1 vectors either singly or in combination. These plasmids were expressed in transfected chicken embryonic fibroblast (CEF) cells. Chloramphenicol acetyltransferase (CAT) activity expressed under the control of the promoter in CEF co-transfected with pP(1.8 kb)-CAT and pBud-pp38-pp24 was significantly higher than that following transfection with only pBud-pp38 or pBud-pp24. This indicates the combination of pp24 and pp38 together are essential for the activation of the promoter. In DNA mobility shift assays, the promoter binds to pp38 and pp24 together, but not to pp38 or pp24 alone. By competitive inhibition tests with a set of DNA fragments from the promoter region, the sequence 5'-CTGCTCATTT-3' was identified as the core sequence for binding by pp38-pp24 in up-regulation of the bi-directional promoter activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619133     DOI: 10.1007/s11262-007-0129-5

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  31 in total

1.  The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers.

Authors:  H Shigekane; Y Kawaguchi; M Shirakata; M Sakaguchi; K Hirai
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation.

Authors:  R F Silva; S M Reddy; B Lupiani
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

4.  Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides.

Authors:  K Ikuta; K Nakajima; M Naito; S H Ann; S Ueda; S Kato; K Hirai
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

5.  Marek's disease virus type 1-specific phosphorylated proteins pp38 and pp24 with common amino acid termini are encoded from the opposite junction regions between the long unique and inverted repeat sequences of viral genome.

Authors:  G S Zhu; A Iwata; M Gong; S Ueda; K Hirai
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

6.  The role of pp38 in regulation of Marek's disease virus bi-directional promoter between pp38 and 1.8-kb mRNA.

Authors:  Jiabo Ding; Zhizhong Cui; Lucy F Lee; Xiaoping Cui; Sanjay M Reddy
Journal:  Virus Genes       Date:  2006-04       Impact factor: 2.332

7.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.

Authors:  L F Lee; X Liu; R L Witter
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

9.  Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV.

Authors:  Q Peng; M Zeng; Z A Bhuiyan; E Ubukata; A Tanaka; M Nonoyama; Y Shirazi
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

Review 10.  Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.

Authors:  J L Liu; H J Kung
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

View more
  4 in total

1.  Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma.

Authors:  Andrew C Brown; Venugopal Nair; Martin J Allday
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  The construction and characterization of the bi-directional promoter between pp38 gene and 1.8-kb mRNA transcripts of Marek's disease viruses.

Authors:  Ruiai Chen; Jiabo Ding; Bin Wang
Journal:  Virol J       Date:  2009-11-30       Impact factor: 4.099

3.  Deletion of 1.8-kb mRNA of Marek's disease virus decreases its replication ability but not oncogenicity.

Authors:  Aijun Sun; Yanpeng Li; Jingyan Wang; Shuai Su; Hongjun Chen; Hongfei Zhu; Jiabo Ding; Zhizhong Cui
Journal:  Virol J       Date:  2010-10-29       Impact factor: 4.099

4.  Construction of recombinant Marek's disease virus (rMDV) co-expressing AIV-H9N2-NA and NDV-F genes under control of MDV's own bi-directional promoter.

Authors:  Zhenjie Zhang; Chengtai Ma; Peng Zhao; Luntao Duan; Wenqing Chen; Fushou Zhang; Zhizhong Cui
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.